Skip to content
MedCompare

Ceftazidime

Infections
Save $56/mo
7× cheaper

Ceftazidime for injection, USP is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: Lower Respiratory Tract Infections, including pneumonia, caused by Pseudomonas aeruginosa and other Pseudomonas spp.; Haemoph…

United States
$65
per month
India
$9
per month
You save
−86%
save $56/mo · 86% cheaper
16.4K US scripts/yr$910.9K potential annual savings$1.1M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC22H22N6O7S2

SMILES: CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]

Compare the price
US price$65per month
India price$15per month
You save$5077% less

Based on 30 units per month. US $2.15 vs India $0.49 per unit.

Total over 1 periodSave $50$65 → $15
The bigger picture

Ceftazidime is filled about 16.4K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$1.1M
If sourced from India
$144.2K
Potential annual savings
$910.9K
−86%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.